The Gap, Inc. (GAP) Tops Q1 EPS by 1c
Tweet
Share
E-mail
Get Alerts GAP Hot Sheet
Join SI Premium – FREE
The Gap, Inc. (NYSE: GAP) reported Q1 EPS of $0.38, $0.01 better than the analyst estimate of $0.37. Revenue for the quarter came in at $3.5 billion versus the consensus estimate of $3.53 billion.
Full Year Fiscal 2026
Current FY 2026 Outlook | Prior FY 2026 Outlook | FY 2025 | |||
Net sales | Up 1% to 2% year-over-year | Up 2% to 3% year-over-year | $15.4 billion | ||
Gross margin | Flat to up slightly year-over-year | Flat to up slightly year-over-year | 40.8 % | ||
Adjusted operating expense (% of net sales) | About flat year-over-year | About flat year-over-year | 33.5 % | ||
Adjusted operating margin | About 7.3% to 7.5% | About 7.3% to 7.5% | 7.3 % | ||
Net interest income | Approximately | Approximately | $17 million | ||
Effective tax rate | Approximately 25% | Approximately 27% | 27.9 % | ||
Diluted weighted average share count | Approximately 375 million | N/A | 384 million | ||
Adjusted diluted earnings per share | Approximately | Approximately | $2.13 | ||
Capital expenditures | Approximately | Approximately $650 million | $470 million | ||
Net store closures 2 | About flat | About flat | 32 |
For earnings history and earnings-related data on The Gap, Inc. (GAP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley upgrades CDW on stronger AI-driven server demand
- Bernstein SocGen Reiterates Outperform Rating on Fervo Energy (FRVO)
- Corbus Pharmaceuticals (CRBP) PT Lowered to $34 at Mizuho
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
